Asthma Clinical Trials in Paris
6 recruitingParis, France
Showing 1–6 of 6 trials
Recruiting
Phase 2
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
Asthma
Eli Lilly and Company531 enrolled121 locationsNCT07219173
Recruiting
Phase 3
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)
Asthma
AstraZeneca200 enrolled112 locationsNCT05692180
Recruiting
Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Asthma
AstraZeneca231 enrolled142 locationsNCT06023589
Recruiting
Phase 3
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
AsthmaWheezing
Sanofi90 enrolled75 locationsNCT06191315
Recruiting
Phase 4
Predictive Signature of Benralizumab Response
Severe AsthmaAsthma; Eosinophilic
Nantes University Hospital220 enrolled20 locationsNCT04565483
Recruiting
Phase 3
REVErsing Airway Remodelling With Tezepelumab
Airway Remodelling, Asthmatic
University Hospital, Montpellier90 enrolled12 locationsNCT05651841